Cancer Center Support Grant (CORE) Renewal View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

1978-2020

FUNDING AMOUNT

26519493 USD

ABSTRACT

? DESCRIPTION (provided by applicant): The Purdue University Center for Cancer Research (PCCR) was established as an NCI basic science cancer center in 1978. As such, the PCCR's mission focuses on basic discovery - discovery that is the foundation through which the PCCR fosters innovative cancer solutions. Notably, the PCCR not only supports basic discovery but also facilitates discovery application and, where possible, positions discoveries for transfer to the public domain. Purdue strengths in engineering, veterinary medicine, nutrition science, chemistry, medicinal chemistry, pharmacy, structural biology, and biological sciences, form the core foundation upon which the PCCR facilitates discovery centered on understanding the biology of the cancer cell, developing innovative technology to probe cancer-related phenomena, creating diagnostic and imaging tools, and synthesizing unique therapeutic chemical entities that can be delivered to the cancer cell by novel technology. To facilitate the mission of discovery, the PCCR has established a transdisciplinary environment that focuses PCCR core strengths on providing novel solutions to cancer problems. As a matrix center, PCCR leadership draws on core capabilities through its 97 members from 18 academic departments and 6 colleges across Purdue, to organize an infrastructure based on four Research Programs: Chemical and Structural Biology (CSB), Cell Identity and Signaling (CIS), Medicinal Chemistry (MC), and Drug Delivery and Molecular Sensing (DDMS). The PCCR expedites discovery through management of 7 Shared Resources (Flow Cytometry and Cell Separation (FC-SR), DNA Sequencing (SEQ-SR), Macromolecular Crystallography (MM-SR), Mass Spectrometry (MS-SR), Nuclear Magnetic Resonance (NMR-SR), Biological Evaluation (BE-SR) and Transgenic Mouse (TMCF-SR)) which provide researchers access to state-of-the-art expertise to analyze cells, nucleic acids and proteins, to determine detailed molecular structures that can be used to design drugs, to evaluate targets/drugs in vivo, and to develop new animal models of cancer. The PCCR fosters a remarkable breadth of cancer research spanning clinical evaluations of dogs with spontaneous malignancies as an evaluative process in drug development and validation of targets and technologies, to probing the fundamentals of molecular motion through interferometry and determining its application for innovative cancer solutions, and the application of the pioneering technology that is based on ionizing molecules in ambient conditions for mass spectrometry analysis to identify cancer markers and which opened doors for additional technological assessments and mechanistic biological studies. Finally, the PCCR maintains the Essential Characteristics for a Cancer Center including exceptional Physical Space, effective Organizational Capabilities that provide the foundation for innovative cancer research, a Transdisciplinary Collaborative environment that facilitates fundamental discovery with a Cancer Focus, exceptional Institutional Commitment to expand and enhance cancer research at Purdue, and outstanding Center Director leadership that drives the development of cancer solutions. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=9516897

Related SciGraph Publications

  • 2019-12. Inferring Gene Regulatory Networks from a Population of Yeast Segregants in SCIENTIFIC REPORTS
  • 2019-12. An Implantable Ultrasonically-Powered Micro-Light-Source (µLight) for Photodynamic Therapy in SCIENTIFIC REPORTS
  • 2019-12. dStruct: identifying differentially reactive regions from RNA structurome profiling data in GENOME BIOLOGY
  • 2019-12. Epigenetic biomarker screening by FLIM-FRET for combination therapy in ER+ breast cancer in CLINICAL EPIGENETICS
  • 2019-02-13. Total Synthesis of trans -Resorcylide via Macrocyclic Stille Carbonylation in THE JOURNAL OF ANTIBIOTICS
  • 2018-12. Expedient syntheses of N-heterocycles via intermolecular amphoteric diamination of allenes in NATURE COMMUNICATIONS
  • 2018-12. Ultrasound beam steering of oxygen nanobubbles for enhanced bladder cancer therapy in SCIENTIFIC REPORTS
  • 2018-12. Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2018-12. Blue light induces a neuroprotective gene expression program in Drosophila photoreceptors in BMC NEUROSCIENCE
  • 2018-12. Characterization and structure-activity relationships of indenoisoquinoline-derived topoisomerase I inhibitors in unsilencing the dormant Ube3a gene associated with Angelman syndrome in MOLECULAR AUTISM
  • 2018-12. Solution structures of multiple G-quadruplex complexes induced by a platinum(II)-based tripod reveal dynamic binding in NATURE COMMUNICATIONS
  • 2018-12. An asparagine/glycine switch governs product specificity of human N-terminal methyltransferase NTMT2 in COMMUNICATIONS BIOLOGY
  • 2018-12. Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer in BREAST CANCER RESEARCH
  • 2018-12. Neutralizing negative epigenetic regulation by HDAC5 enhances human haematopoietic stem cell homing and engraftment in NATURE COMMUNICATIONS
  • 2018-10. Biased signaling downstream of epidermal growth factor receptor regulates proliferative versus apoptotic response to ligand in CELL DEATH & DISEASE
  • 2018-05. Immunologic and gene expression profiles of spontaneous canine oligodendrogliomas in JOURNAL OF NEURO-ONCOLOGY
  • 2018-02-08. Plk1 phosphorylation of Numb leads to impaired DNA damage response in ONCOGENE
  • 2017-12. Pluronic based β-cyclodextrin polyrotaxanes for treatment of Niemann-Pick Type C disease in SCIENTIFIC REPORTS
  • 2017-12. X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility for structure-based drug design in SCIENTIFIC REPORTS
  • 2017-12. Cytochrome b5 protects photoreceptors from light stress-induced lipid peroxidation and retinal degeneration in NPJ AGING AND MECHANISMS OF DISEASE
  • 2017-12. Transcriptome profiling of aging Drosophila photoreceptors reveals gene expression trends that correlate with visual senescence in BMC GENOMICS
  • 2017-12. KANK1 inhibits cell growth by inducing apoptosis through regulating CXXC5 in human malignant peripheral nerve sheath tumors in SCIENTIFIC REPORTS
  • 2017-12. Oxygen nanobubbles revert hypoxia by methylation programming in SCIENTIFIC REPORTS
  • 2017-11. Altered metabolite levels and correlations in patients with colorectal cancer and polyps detected using seemingly unrelated regression analysis in METABOLOMICS
  • 2017-07. Contraction of intestinal effector T cells by retinoic acid-induced purinergic receptor P2X7 in MUCOSAL IMMUNOLOGY
  • 2017-06. Retinoic acid directs breast cancer cell state changes through regulation of TET2-PKCζ pathway in ONCOGENE
  • 2017-04. DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection in ONCOGENE
  • 2017-03. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth in ONCOGENE
  • 2017-01-17. Pten is necessary for the quiescence and maintenance of adult muscle stem cells in NATURE COMMUNICATIONS
  • 2016-12. Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer in ONCOGENE
  • 2016-12. Deletion of Lkb1 in adult mice results in body weight reduction and lethality in SCIENTIFIC REPORTS
  • 2016-10. Selective Capture of Histidine-tagged Proteins from Cell Lysates Using TEM grids Modified with NTA-Graphene Oxide in SCIENTIFIC REPORTS
  • 2016-09. Zwitterionic chitosan for the systemic treatment of sepsis in SCIENTIFIC REPORTS
  • 2016-09. Evolutionary and developmental analysis reveals KANK genes were co-opted for vertebrate vascular development in SCIENTIFIC REPORTS
  • 2016-09. X-Ray Structure and Inhibition of 3C-like Protease from Porcine Epidemic Diarrhea Virus in SCIENTIFIC REPORTS
  • 2016-05. Ubiquitination independent of E1 and E2 enzymes by bacterial effectors in NATURE
  • 2016-04. An Inducible, Large-Intestine-Specific Transgenic Mouse Model for Colitis and Colitis-Induced Colon Cancer Research in DIGESTIVE DISEASES AND SCIENCES
  • 2016-02. Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2 in ONCOGENE
  • 2016. Tol2-Mediated Delivery of miRNAs to the Chicken Otocyst Using Plasmid Electroporation in AUDITORY AND VESTIBULAR RESEARCH
  • 2015-12. RNA-guided CRISPR-Cas technologies for genome-scale investigation of disease processes in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2015-12. Selective increase in subtelomeric DNA methylation: an epigenetic biomarker for malignant glioma in CLINICAL EPIGENETICS
  • 2015-09. Folate receptor expression on murine and human adipose tissue macrophages in INFLAMMATION RESEARCH
  • 2015-07. Assessing Cholesterol Storage in Live Cells and C. elegans by Stimulated Raman Scattering Imaging of Phenyl-Diyne Cholesterol in SCIENTIFIC REPORTS
  • 2015-05. Direct Visualization of De novo Lipogenesis in Single Living Cells in SCIENTIFIC REPORTS
  • 2015-04. Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant Staphylococci in THE JOURNAL OF ANTIBIOTICS
  • 2015. Measuring Helicase Inhibition of the DEAD-Box Protein Dbp2 by Yra1 in RNA REMODELING PROTEINS
  • 2014-06. Quantitative imaging of single mRNA splice variants in living cells in NATURE NANOTECHNOLOGY
  • 2012-09-23. Crystal structure of the multidrug transporter P-glycoprotein from Caenorhabditis elegans in NATURE
  • 2011-09. Domain cooperativity in multidomain proteins: what can we learn from molecular alignment in anisotropic media? in JOURNAL OF BIOMOLECULAR NMR
  • 2009-10. Design of Multifunctional Nanomedical Systems in ANNALS OF BIOMEDICAL ENGINEERING
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2206", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "type": "DefinedTerm"
          }
        ], 
        "amount": {
          "currency": "USD", 
          "type": "MonetaryAmount", 
          "value": "26519493"
        }, 
        "description": "? DESCRIPTION (provided by applicant): The Purdue University Center for Cancer Research (PCCR) was established as an NCI basic science cancer center in 1978. As such, the PCCR's mission focuses on basic discovery - discovery that is the foundation through which the PCCR fosters innovative cancer solutions. Notably, the PCCR not only supports basic discovery but also facilitates discovery application and, where possible, positions discoveries for transfer to the public domain. Purdue strengths in engineering, veterinary medicine, nutrition science, chemistry, medicinal chemistry, pharmacy, structural biology, and biological sciences, form the core foundation upon which the PCCR facilitates discovery centered on understanding the biology of the cancer cell, developing innovative technology to probe cancer-related phenomena, creating diagnostic and imaging tools, and synthesizing unique therapeutic chemical entities that can be delivered to the cancer cell by novel technology. To facilitate the mission of discovery, the PCCR has established a transdisciplinary environment that focuses PCCR core strengths on providing novel solutions to cancer problems. As a matrix center, PCCR leadership draws on core capabilities through its 97 members from 18 academic departments and 6 colleges across Purdue, to organize an infrastructure based on four Research Programs: Chemical and Structural Biology (CSB), Cell Identity and Signaling (CIS), Medicinal Chemistry (MC), and Drug Delivery and Molecular Sensing (DDMS). The PCCR expedites discovery through management of 7 Shared Resources (Flow Cytometry and Cell Separation (FC-SR), DNA Sequencing (SEQ-SR), Macromolecular Crystallography (MM-SR), Mass Spectrometry (MS-SR), Nuclear Magnetic Resonance (NMR-SR), Biological Evaluation (BE-SR) and Transgenic Mouse (TMCF-SR)) which provide researchers access to state-of-the-art expertise to analyze cells, nucleic acids and proteins, to determine detailed molecular structures that can be used to design drugs, to evaluate targets/drugs in vivo, and to develop new animal models of cancer. The PCCR fosters a remarkable breadth of cancer research spanning clinical evaluations of dogs with spontaneous malignancies as an evaluative process in drug development and validation of targets and technologies, to probing the fundamentals of molecular motion through interferometry and determining its application for innovative cancer solutions, and the application of the pioneering technology that is based on ionizing molecules in ambient conditions for mass spectrometry analysis to identify cancer markers and which opened doors for additional technological assessments and mechanistic biological studies. Finally, the PCCR maintains the Essential Characteristics for a Cancer Center including exceptional Physical Space, effective Organizational Capabilities that provide the foundation for innovative cancer research, a Transdisciplinary Collaborative environment that facilitates fundamental discovery with a Cancer Focus, exceptional Institutional Commitment to expand and enhance cancer research at Purdue, and outstanding Center Director leadership that drives the development of cancer solutions.", 
        "endDate": "2020-06-30T00:00:00Z", 
        "funder": {
          "id": "https://www.grid.ac/institutes/grid.48336.3a", 
          "type": "Organization"
        }, 
        "id": "sg:grant.2438840", 
        "identifier": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "2438840"
            ]
          }, 
          {
            "name": "nih_id", 
            "type": "PropertyValue", 
            "value": [
              "P30CA023168"
            ]
          }
        ], 
        "inLanguage": [
          "en"
        ], 
        "keywords": [
          "application", 
          "applicants", 
          "clinical evaluation", 
          "description", 
          "foundation", 
          "TMCF-SR", 
          "cancer solutions", 
          "cancer markers", 
          "dogs", 
          "cancer center", 
          "Shared Resources", 
          "management", 
          "DDMS", 
          "NCI basic science cancer center", 
          "technology", 
          "exceptional Institutional Commitment", 
          "new animal model", 
          "basic discoveries", 
          "Purdue strengths", 
          "cis", 
          "discovery applications", 
          "college", 
          "molecules", 
          "imaging tools", 
          "detailed molecular structure", 
          "renewal", 
          "development", 
          "structural biology", 
          "cell separation", 
          "MM-SR", 
          "biological evaluation", 
          "flow cytometry", 
          "Essential Characteristics", 
          "transdisciplinary environment", 
          "basic discovery - discovery", 
          "innovative cancer solutions", 
          "PCCR", 
          "PCCR leadership", 
          "fundamentals", 
          "ambient conditions", 
          "Purdue", 
          "remarkable breadth", 
          "signaling", 
          "novel technology", 
          "mass spectrometry analysis", 
          "matrix center", 
          "evaluative process", 
          "target", 
          "DNA sequencing", 
          "cancer", 
          "CSB", 
          "Research Programs", 
          "cell identity", 
          "core foundation", 
          "Cancer Center Support Grant", 
          "macromolecular crystallography", 
          "cancer focus", 
          "core", 
          "spontaneous malignancies", 
          "members", 
          "FC-SR", 
          "door", 
          "chemistry", 
          "mission", 
          "researchers", 
          "exceptional Physical Space", 
          "PCCR core strengths", 
          "transfer", 
          "interferometry", 
          "mechanistic biological studies", 
          "infrastructure", 
          "transgenic mice", 
          "PCCR's mission", 
          "Purdue University's Center", 
          "mass spectrometry", 
          "cancer research", 
          "nutrition science", 
          "veterinary medicine", 
          "position discovery", 
          "cells", 
          "Transdisciplinary Collaborative environment", 
          "nuclear magnetic resonance", 
          "drugs", 
          "probe cancer", 
          "biology", 
          "medicinal chemistry", 
          "art expertise", 
          "molecular motion", 
          "NMR-SR", 
          "targets/drugs", 
          "chemical", 
          "molecular sensing", 
          "academic departments", 
          "drug development", 
          "additional technological assessments", 
          "public domain", 
          "effective Organizational Capabilities", 
          "drug delivery", 
          "cancer cells", 
          "pharmacy", 
          "innovative technologies", 
          "discovery", 
          "SEQ-SR", 
          "outstanding Center Director leadership", 
          "MS-SR", 
          "protein", 
          "vivo", 
          "biological sciences", 
          "cancer problem", 
          "pioneering technology", 
          "nucleic acids", 
          "validation", 
          "innovative cancer research", 
          "phenomena", 
          "novel solution", 
          "BE-SR", 
          "engineering", 
          "unique therapeutic chemical entities", 
          "core capabilities", 
          "fundamental discoveries", 
          "state"
        ], 
        "name": "Cancer Center Support Grant (CORE) Renewal", 
        "recipient": [
          {
            "id": "https://www.grid.ac/institutes/grid.169077.e", 
            "type": "Organization"
          }, 
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.169077.e", 
              "name": "PURDUE UNIVERSITY", 
              "type": "Organization"
            }, 
            "familyName": "RATLIFF", 
            "givenName": "TIMOTHY L.", 
            "id": "sg:person.010434133617.26", 
            "type": "Person"
          }, 
          {
            "member": "sg:person.010434133617.26", 
            "roleName": "PI", 
            "type": "Role"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/details/grant/grant.2438840"
        ], 
        "sdDataset": "grants", 
        "sdDatePublished": "2019-03-07T12:11", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_4.xml.gz", 
        "startDate": "1978-04-01T00:00:00Z", 
        "type": "MonetaryGrant", 
        "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=9516897"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2438840'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2438840'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2438840'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2438840'


     

    This table displays all metadata directly associated to this object as RDF triples.

    165 TRIPLES      19 PREDICATES      143 URIs      135 LITERALS      5 BLANK NODES

    Subject Predicate Object
    1 sg:grant.2438840 schema:about anzsrc-for:2206
    2 schema:amount Ne4d53560942249e3bc9764539e2a0f04
    3 schema:description ? DESCRIPTION (provided by applicant): The Purdue University Center for Cancer Research (PCCR) was established as an NCI basic science cancer center in 1978. As such, the PCCR's mission focuses on basic discovery - discovery that is the foundation through which the PCCR fosters innovative cancer solutions. Notably, the PCCR not only supports basic discovery but also facilitates discovery application and, where possible, positions discoveries for transfer to the public domain. Purdue strengths in engineering, veterinary medicine, nutrition science, chemistry, medicinal chemistry, pharmacy, structural biology, and biological sciences, form the core foundation upon which the PCCR facilitates discovery centered on understanding the biology of the cancer cell, developing innovative technology to probe cancer-related phenomena, creating diagnostic and imaging tools, and synthesizing unique therapeutic chemical entities that can be delivered to the cancer cell by novel technology. To facilitate the mission of discovery, the PCCR has established a transdisciplinary environment that focuses PCCR core strengths on providing novel solutions to cancer problems. As a matrix center, PCCR leadership draws on core capabilities through its 97 members from 18 academic departments and 6 colleges across Purdue, to organize an infrastructure based on four Research Programs: Chemical and Structural Biology (CSB), Cell Identity and Signaling (CIS), Medicinal Chemistry (MC), and Drug Delivery and Molecular Sensing (DDMS). The PCCR expedites discovery through management of 7 Shared Resources (Flow Cytometry and Cell Separation (FC-SR), DNA Sequencing (SEQ-SR), Macromolecular Crystallography (MM-SR), Mass Spectrometry (MS-SR), Nuclear Magnetic Resonance (NMR-SR), Biological Evaluation (BE-SR) and Transgenic Mouse (TMCF-SR)) which provide researchers access to state-of-the-art expertise to analyze cells, nucleic acids and proteins, to determine detailed molecular structures that can be used to design drugs, to evaluate targets/drugs in vivo, and to develop new animal models of cancer. The PCCR fosters a remarkable breadth of cancer research spanning clinical evaluations of dogs with spontaneous malignancies as an evaluative process in drug development and validation of targets and technologies, to probing the fundamentals of molecular motion through interferometry and determining its application for innovative cancer solutions, and the application of the pioneering technology that is based on ionizing molecules in ambient conditions for mass spectrometry analysis to identify cancer markers and which opened doors for additional technological assessments and mechanistic biological studies. Finally, the PCCR maintains the Essential Characteristics for a Cancer Center including exceptional Physical Space, effective Organizational Capabilities that provide the foundation for innovative cancer research, a Transdisciplinary Collaborative environment that facilitates fundamental discovery with a Cancer Focus, exceptional Institutional Commitment to expand and enhance cancer research at Purdue, and outstanding Center Director leadership that drives the development of cancer solutions.
    4 schema:endDate 2020-06-30T00:00:00Z
    5 schema:funder https://www.grid.ac/institutes/grid.48336.3a
    6 schema:identifier N4434f656f96a46a787a1ec06c97ffad4
    7 Na50f41f2ca844e358141f616cadad11d
    8 schema:inLanguage en
    9 schema:keywords BE-SR
    10 CSB
    11 Cancer Center Support Grant
    12 DDMS
    13 DNA sequencing
    14 Essential Characteristics
    15 FC-SR
    16 MM-SR
    17 MS-SR
    18 NCI basic science cancer center
    19 NMR-SR
    20 PCCR
    21 PCCR core strengths
    22 PCCR leadership
    23 PCCR's mission
    24 Purdue
    25 Purdue University's Center
    26 Purdue strengths
    27 Research Programs
    28 SEQ-SR
    29 Shared Resources
    30 TMCF-SR
    31 Transdisciplinary Collaborative environment
    32 academic departments
    33 additional technological assessments
    34 ambient conditions
    35 applicants
    36 application
    37 art expertise
    38 basic discoveries
    39 basic discovery - discovery
    40 biological evaluation
    41 biological sciences
    42 biology
    43 cancer
    44 cancer cells
    45 cancer center
    46 cancer focus
    47 cancer markers
    48 cancer problem
    49 cancer research
    50 cancer solutions
    51 cell identity
    52 cell separation
    53 cells
    54 chemical
    55 chemistry
    56 cis
    57 clinical evaluation
    58 college
    59 core
    60 core capabilities
    61 core foundation
    62 description
    63 detailed molecular structure
    64 development
    65 discovery
    66 discovery applications
    67 dogs
    68 door
    69 drug delivery
    70 drug development
    71 drugs
    72 effective Organizational Capabilities
    73 engineering
    74 evaluative process
    75 exceptional Institutional Commitment
    76 exceptional Physical Space
    77 flow cytometry
    78 foundation
    79 fundamental discoveries
    80 fundamentals
    81 imaging tools
    82 infrastructure
    83 innovative cancer research
    84 innovative cancer solutions
    85 innovative technologies
    86 interferometry
    87 macromolecular crystallography
    88 management
    89 mass spectrometry
    90 mass spectrometry analysis
    91 matrix center
    92 mechanistic biological studies
    93 medicinal chemistry
    94 members
    95 mission
    96 molecular motion
    97 molecular sensing
    98 molecules
    99 new animal model
    100 novel solution
    101 novel technology
    102 nuclear magnetic resonance
    103 nucleic acids
    104 nutrition science
    105 outstanding Center Director leadership
    106 pharmacy
    107 phenomena
    108 pioneering technology
    109 position discovery
    110 probe cancer
    111 protein
    112 public domain
    113 remarkable breadth
    114 renewal
    115 researchers
    116 signaling
    117 spontaneous malignancies
    118 state
    119 structural biology
    120 target
    121 targets/drugs
    122 technology
    123 transdisciplinary environment
    124 transfer
    125 transgenic mice
    126 unique therapeutic chemical entities
    127 validation
    128 veterinary medicine
    129 vivo
    130 schema:name Cancer Center Support Grant (CORE) Renewal
    131 schema:recipient N92881b8586934f0088c9a161db13afe5
    132 sg:person.010434133617.26
    133 https://www.grid.ac/institutes/grid.169077.e
    134 schema:sameAs https://app.dimensions.ai/details/grant/grant.2438840
    135 schema:sdDatePublished 2019-03-07T12:11
    136 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    137 schema:sdPublisher N282fda393166452199c4a341aa568432
    138 schema:startDate 1978-04-01T00:00:00Z
    139 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=9516897
    140 sgo:license sg:explorer/license/
    141 sgo:sdDataset grants
    142 rdf:type schema:MonetaryGrant
    143 N282fda393166452199c4a341aa568432 schema:name Springer Nature - SN SciGraph project
    144 rdf:type schema:Organization
    145 N4434f656f96a46a787a1ec06c97ffad4 schema:name nih_id
    146 schema:value P30CA023168
    147 rdf:type schema:PropertyValue
    148 N92881b8586934f0088c9a161db13afe5 schema:member sg:person.010434133617.26
    149 schema:roleName PI
    150 rdf:type schema:Role
    151 Na50f41f2ca844e358141f616cadad11d schema:name dimensions_id
    152 schema:value 2438840
    153 rdf:type schema:PropertyValue
    154 Ne4d53560942249e3bc9764539e2a0f04 schema:currency USD
    155 schema:value 26519493
    156 rdf:type schema:MonetaryAmount
    157 anzsrc-for:2206 schema:inDefinedTermSet anzsrc-for:
    158 rdf:type schema:DefinedTerm
    159 sg:person.010434133617.26 schema:affiliation https://www.grid.ac/institutes/grid.169077.e
    160 schema:familyName RATLIFF
    161 schema:givenName TIMOTHY L.
    162 rdf:type schema:Person
    163 https://www.grid.ac/institutes/grid.169077.e schema:name PURDUE UNIVERSITY
    164 rdf:type schema:Organization
    165 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...